Inborn errors of metabolism

Inborn errors of metabolism comprise a large class of geneticdiseasesinvolving disorders of metabolism. The majority are due to defects of single genesthat code for enzymesthat facilitate conversion of various substances (substrates) into others (products). In most of the disorders, problems arise due to accumulation of substances which are toxic or interfere with normal function, or to the effects of reduced ability to synthesize essential compounds. Inborn errors of metabolism are now often referred to as congenital metabolic diseases or inherited metabolic diseases, and these terms are considered synonymous.

The term inborn error of metabolism was coined by a British physician, Archibald Garrod(1857-1936), in the early 20th century. He is known for the "one gene, one enzyme" hypothesis, which arose from his studies on the nature and inheritance of alkaptonuria. His seminal text, Inborn Errors of Metabolismwas published in 1923.

Major categories of inherited metabolic diseases

Traditionally the inherited metabolic diseases were categorized as disorders of carbohydratemetabolism, amino acidmetabolism, organic acidmetabolism, or lysosomal storage diseases. In recent decades, hundreds of new inherited disorders of metabolism have been discovered and the categories have proliferated. Following are some of the major classes of congenital metabolic diseases, with prominent examples of each class. Many others do not fall into these categories. ICD-10codes are provided where available.

• Disorders of carbohydratemetabolism
  • E.g., glycogen storage disease(E74.0)
• Disorders of amino acidmetabolism
  • E.g., phenylketonuria(E70.0), maple syrup urine disease(E71.0)
• Disorders of organic acid metabolism
  • E.g., alcaptonuria(E70.2)
• Disorders of fatty acid oxidation and mitochondrialmetabolism
  • E.g., medium chain acyl dehydrogenase deficiency
• Disorders of porphyrinmetabolism
  • E.g., acute intermittent porphyria(E80.2)
• Disorders of purineor pyrimidinemetabolism
  • E.g., Lesch-Nyhan syndrome(E79.1)
• Disorders of steroidmetabolism
  • E.g., congenital adrenal hyperplasia(E25.0)
• Disorders of mitochondrialfunction
  • E.g., Kearns-Sayre syndrome(H49.8)
• Disorders of peroxisomalfunction
  • E.g., Zellweger syndrome(Q87.8)
• Lysosomal storage disorders
  • E.g., Gaucher's disease(E75.22)

Manifestations and presentations

Because of the enormous number of these diseases and wide range of systems affected, nearly every "presenting complaint" to a doctor may have a congenital metabolic disease as a possible cause, especially in childhood. The following are examples of potential manifestations affecting each of the major organ systems:

• Growth failure, failure to thrive, weight loss
• Ambiguous genitalia, delayed puberty, precocious puberty
• Developmental delay, seizures, dementia, encephalopathy, stroke
• Deafness, blindness, pain agnosia
• Skin rash, abnormal pigmentation, lack of pigmentation, excessive hair growth, lumps and bumps
• Dental abnormalities
• Immunodeficiency, thrombocytopenia, anemia, enlarged spleen, enlarged lymph nodes
• Many forms of cancer
• Recurrent vomiting, diarrhea, abdominal pain
• Excessive urination, renal failure, dehydration, edema
• Hypotension, heart failure, enlarged heart, hypertension, myocardial infarction
• Hepatomegaly, jaundice, liver failure
• Unusual facial features, congenital malformations
• Excessive breathing (hyperventilation), respiratory failure
• Abnormal behavior, depression, psychosis
• Joint pain, muscleweakness, cramps
• Hypothyroidism, adrenal insufficiency, hypogonadism, diabetes mellitus

Diagnostic techniques

Because of the multiplicity of conditions, many different diagnostic testsare used for screening. An abnormal result is often followed by a subsequent "definitive test" to confirm the suspected diagnosis.

Common screening tests used in the last sixty years:

• Ferric chloride test(turned colors in reaction to various abnormal metabolites in urine)
• Ninhydrinpaper chromatography(detected abnormal amino acidpatterns)
• Guthrie bacterial inhibition assay(detected a few amino acids in excessive amounts in blood)
• Quantitative plasma amino acids, quantitative urine amino acids
• Urine organic acids by mass spectrometry

Specific diagnostic tests (or focused screening for a small set of disorders):

• Tissue biopsyor necropsy: liver, muscle, brain, bone marrow
• Skin biopsy and fibroblast cultivation for specific enzyme testing
• Specific DNA testing

Newborn screening

Dozens of congenital metabolic diseases are now detectable by newborn screeningtests, especially the expanded testing using mass spectrometry. This is an increasingly common way for the diagnosis to be made and sometimes results in earlier treatment and a better outcome.

Management

In the middle of the 20th century the principal treatment for some of the amino acid disorderswas restriction of dietary protein and all other care was simply management of complications. In the last two decades, enzyme replacement, gene transfer, and organ transplantation have become available and beneficial for many previously untreatable disorders. Some of the more common or promising are listed.

• Dietary restriction
  • E.g., reduction of dietary protein remains a mainstay of treatment for phenylketonuriaand other amino acid disorders.
• Dietary supplementation or replacement
  • E.g., cornstarch several times a day helps prevent people with glycogen storage diseasefrom becoming hypoglycemicas quickly.
• Vitamins
  • E.g., thiaminesupplementation benefits several types of lactic acidosis.
• Intermediary metabolites, compounds, or drugs that facilitate or retard specific metabolic pathways
  • E.g.,
• Dialysis
  • E.g.,
• Enzyme replacement
  • E.g.,
• Gene transfer
  • E.g.,
• Bone marrow or organ transplantation
  • E.g.,
• Treatment of symptoms and complications
  • E.g.,
• Prenatal diagnosis and avoidance of pregnancy or abortion of an affected fetus
  • E.g.,

References

More than most fields in medicine, this specialty has a single definitive, monumental text: The Metabolic and Molecular Bases of Inherited Disease, by Charles R. Scriver (Editor), William S. Sly (Editor), Barton Childs, Arthur L. Beaudet, David Valle, Kenneth W. Kinzler, Bert Vogelstein. New York:McGraw-Hill. 8th edition, 2001, 4 volumes, ISBN 0079130356

The most useful reference source on the web for these diseases is the Online Mendelian Inheritance databasemaintained by the National Library of Medicine.fr:Maladie métabolique congénitale

This article is licensed under the GNU Free Documentation License.
It uses material from the http://en.wikipedia.org/wiki/Inborn+errors+of+metabolism Wikipedia article Inborn errors of metabolism.